Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis.

Joerg MahlichAkiko TsubotaKeiichiro ImanakaKentaro Enjo

Published in: Current medical research and opinion (2018)

The overall costs of chemotherapy for patients diagnosed with castration-resistant prostate cancer in Japan are high. Our findings can serve as a basis for health economic evaluations.

Keyphrases

newly diagnosed
ejection fraction
healthcare
public health
radiation therapy
social media
climate change